The above findings provide evidence of a significant influence of the NLRP3 inflammasome activity on the development of COPD and pointed out that inhibition of NLRP3 inflammasome activity efficiently ameliorates the symptoms of COPD (37–39, 41–43). The gene discussed is NLRP3; the disease is chronic obstructive pulmonary disease.